The Transformation of AML Therapy: Updates in Front-Line and Maintenance Therapies and Considerations for Older Patients
A 1.0-hour Accredited On-Demand Virtual Symposium conducted in conjunction with HOPA 2021
AbbVie and Bristol Myers Squibb.
Faculty Presenters
Alison P. Duffy, PharmD, BCOP
Associate Professor
University of Maryland School of Pharmacy
Clinical Pharmacy Specialist, Oncology
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland
Matthew Newman, PharmD, BCOP
Clinical Pharmacist Practitioner, Hematologic Malignancies
The Johns Hopkins Hospital
Baltimore, Maryland
Program Description
Acute myeloid leukemia (AML) is a hematological malignancy affecting a projected 20,000 individuals in the year 2020. The traditional treatment for AML consists of intensive induction chemotherapy, followed by consolidation therapy. Treatment strategies are tailored based on patient-specific factors, including molecular mutations, comorbidities, and age. This activity will focus on many novel agents used in the treatment of AML, including targeted agents and the role of hypomethylating agents in maintenance therapy. Additionally, the role of the pharmacist in the management of patients with AML will be highlighted, emphasizing optimal care strategies for patients during the COVID-19 pandemic.
Target audience: Health-system pharmacists and oncology pharmacists
Type of activity: Application
Release date: May 4, 2021
Expiration date: May 4, 2022
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine recent drug approvals and clinical updates to investigational therapies in acute myeloid leukemia (AML) treatment
- Explain clinical trial data supporting the use of maintenance therapies, including hypomethylating agents, in the treatment of AML
- Identify challenges and potential opportunities for pharmacists to improve care for older patients with AML particularly in the setting of COVID-19
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-179-H01-P. The activity is available for CE credit through May 4, 2022.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Faculty
Alison P. Duffy, PharmD, BCOP, has the following relevant financial relationship with a commercial interest to disclose:
- Speakers Bureau: Amgen
Matthew Newman, PharmD, BCOP, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy Seung, PharmD, BCOP, FHOPA; Meg Croom Taylor, PharmD, CPP; Ann Marciano; Crissy Wilson; Kelly McCormick; Susan Pordon; and Brianna Winters have no financial relationships with commercial interests to disclose.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
Privacy Policy and Terms of Use Information:
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
